Tag #Drug Delivery

Showing 1 to 10 of 10 results

theglobeandmail.com

🌐 85% Global Worthiness

Sep 18, 16:19

Novo Nordisk Partners with Pocketpills for Ozempic and Wegovy Home Delivery

Novo Nordisk Canada has partnered with Pocketpills, a Canadian online pharmacy, to offer home delivery of its diabetes and obesity drugs, Ozempic and Wegovy, streamlining the ordering process and providing discounts.

Novo Nordisk Partners with Pocketpills for Ozempic and Wegovy Home Delivery

Novo Nordisk Canada has partnered with Pocketpills, a Canadian online pharmacy, to offer home delivery of its diabetes and obesity drugs, Ozempic and Wegovy, streamlining the ordering process and providing discounts.

Progress

16% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does this partnership reflect broader trends in the pharmaceutical industry?

This collaboration exemplifies a global shift toward drugmakers connecting directly with patients, offering convenience and potentially reducing healthcare costs and time spent at pharmacies or doctors' offices. This direct-to-consumer model is gaining traction as patient demand increases.

pt.euronews.com

🌐 85% Global Worthiness

Aug 12, 16:19

Weekly Parkinson's Injection Offers Hope for Millions

Australian scientists created a weekly injection combining Levodopa and Carbidopa to treat Parkinson's disease, improving adherence for the 10 million+ sufferers globally, with men affected 1.5 times more often than women.

Weekly Parkinson's Injection Offers Hope for Millions

Australian scientists created a weekly injection combining Levodopa and Carbidopa to treat Parkinson's disease, improving adherence for the 10 million+ sufferers globally, with men affected 1.5 times more often than women.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the key challenges associated with current Parkinson's medication, and how does the new injection address these challenges?

The new injection addresses the significant challenge of medication adherence in Parkinson's patients, where nearly 50% fail to take prescribed medication. Missed doses severely impact daily life, hindering activities and increasing fall risks. The weekly injection aims to mitigate these issues, offering a more convenient and potentially life-changing treatment option.

elpais.com

🌐 90% Global Worthiness

Jul 23, 10:16

€3.1 Million Grant to Revolutionize Cancer Treatment via Targeted Nanomedicine Delivery

Jesús Santamaría, a Spanish chemical engineer, received a €3.1 million grant to improve cancer treatment by addressing the challenge of delivering nanomedicines to tumors, using a novel 'Trojan Horse' strategy.

€3.1 Million Grant to Revolutionize Cancer Treatment via Targeted Nanomedicine Delivery

Jesús Santamaría, a Spanish chemical engineer, received a €3.1 million grant to improve cancer treatment by addressing the challenge of delivering nanomedicines to tumors, using a novel 'Trojan Horse' strategy.

Progress

36% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the primary focus of Jesús Santamaría's €3.1 million research grant, and what is its potential impact on cancer treatment?

Jesús Santamaría, a 66-year-old chemical engineer, received a €3.1 million grant to improve cancer treatment. His research focuses on overcoming the challenge of delivering nanomedicines to tumors, as currently, only 0.7% of the injected nanoparticles reach their target.

foxnews.com

🌐 85% Global Worthiness

Apr 30, 13:14

CRISPR-Edited Microglia Show Promise in Reversing Alzheimer's in Mice

UCI scientists have developed a new Alzheimer's treatment using CRISPR gene-edited microglia immune cells to break down amyloid plaques in mice, reversing neurodegeneration; this targeted therapy may help overcome the blood-brain barrier, offering a promising new avenue for Alzheimer's and other neu...

CRISPR-Edited Microglia Show Promise in Reversing Alzheimer's in Mice

UCI scientists have developed a new Alzheimer's treatment using CRISPR gene-edited microglia immune cells to break down amyloid plaques in mice, reversing neurodegeneration; this targeted therapy may help overcome the blood-brain barrier, offering a promising new avenue for Alzheimer's and other neu...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of UCI's new Alzheimer's treatment, and how does it address current challenges in treating the disease?

UCI scientists have developed a new Alzheimer's treatment using CRISPR gene editing to modify microglia immune cells, enabling them to break down amyloid plaques in mice brains, reversing neurodegeneration. This approach uses the brain's own immune system as a targeted drug delivery system, potentially reducing side effects.

jpost.com

🌐 90% Global Worthiness

Dec 23, 07:08

Nanoparticle Drug Delivery Boosts Cancer Treatment Effectiveness

Tel Aviv University researchers created nanoparticles delivering two cancer-fighting drugs simultaneously to tumors, increasing effectiveness and reducing side effects; animal tests showed tumors shrank significantly, and mice lived up to three times longer than untreated mice.

Nanoparticle Drug Delivery Boosts Cancer Treatment Effectiveness

Tel Aviv University researchers created nanoparticles delivering two cancer-fighting drugs simultaneously to tumors, increasing effectiveness and reducing side effects; animal tests showed tumors shrank significantly, and mice lived up to three times longer than untreated mice.

Progress

32% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does this new nanoparticle drug delivery system improve upon current cancer treatments, and what are the immediate implications for patient outcomes?

Tel Aviv University researchers developed nanoparticles delivering two cancer drugs simultaneously to tumors, significantly improving treatment effectiveness and reducing side effects in animal models. Tumor shrinkage was substantially increased, extending lifespan by up to three times compared to untreated mice.

euronews.com

🌐 85% Global Worthiness

Aug 12, 10:17

Weekly Parkinson's Injection Shows Promise

Australian researchers created a weekly injection for Parkinson's, combining Levodopa and Carbidopa, to improve adherence and reduce the risk of falls among the over 10 million people globally affected by the disease; animal testing is planned.

Weekly Parkinson's Injection Shows Promise

Australian researchers created a weekly injection for Parkinson's, combining Levodopa and Carbidopa, to improve adherence and reduce the risk of falls among the over 10 million people globally affected by the disease; animal testing is planned.

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the combined Levodopa and Carbidopa injection address the challenges associated with the current multi-pill daily regimen?

The new injection aims to improve medication adherence in Parkinson's patients, who currently take multiple daily pills. Poor adherence leads to inconsistent symptom management and increased fall risk. The long-lasting injection addresses this by simplifying the medication regimen, potentially improving quality of life for over 10 million people globally affected by Parkinson's disease.

smh.com.au

🌐 85% Global Worthiness

Jul 29, 22:17

Edible Medicines: Growing Peptides in Plants

Australian researchers are using a $1.2 million grant to develop edible medicines by growing peptides with pain-relieving, cholesterol-lowering, and appetite-suppressing properties in plants, using a robot-powered plant factory in Sydney and aiming for human trials in three years.

Edible Medicines: Growing Peptides in Plants

Australian researchers are using a $1.2 million grant to develop edible medicines by growing peptides with pain-relieving, cholesterol-lowering, and appetite-suppressing properties in plants, using a robot-powered plant factory in Sydney and aiming for human trials in three years.

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the use of automated plant factories enhance the efficiency and scalability of this peptide-based food production?

This research builds upon decades of work on cyclotides, circular peptides resistant to digestion, discovered in plants and venom. The project leverages a robot-powered plant factory to efficiently grow these modified plants, potentially addressing issues like pain, obesity, and high cholesterol. The team aims to produce food products ready for trials within three years, but regulatory hurdles around nutraceuticals versus pharmaceuticals remain.

dailymail.co.uk

🌐 85% Global Worthiness

May 26, 16:12

Ubrogepant Shown to Effectively Treat Premonitory Migraine Symptoms

A King's College London study found that the drug ubrogepant, already used to treat migraine pain, also effectively reduces premonitory symptoms like fatigue and neck pain in up to 80 percent of migraine sufferers, potentially offering earlier intervention and improved quality of life.

Ubrogepant Shown to Effectively Treat Premonitory Migraine Symptoms

A King's College London study found that the drug ubrogepant, already used to treat migraine pain, also effectively reduces premonitory symptoms like fatigue and neck pain in up to 80 percent of migraine sufferers, potentially offering earlier intervention and improved quality of life.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the significance of ubrogepant's efficacy in treating premonitory migraine symptoms?

A new study from King's College London demonstrates that ubrogepant, a drug already used for migraine pain relief, effectively reduces premonitory migraine symptoms in 438 participants. Participants using ubrogepant experienced significantly fewer symptoms, including neck pain and fatigue, and improved concentration within hours. This represents a potential breakthrough for the approximately 80% of migraine sufferers who experience these early symptoms.

dw.com

🌐 85% Global Worthiness

Mar 20, 13:16

3D-Printed Medication Improves Pediatric Cancer Treatment

A research team at Hamburg-Ependorf University Hospital uses a 3D printer to create customized, palatable medication for children undergoing cancer treatment, improving adherence and solving dosage problems; the study runs until 2026.

3D-Printed Medication Improves Pediatric Cancer Treatment

A research team at Hamburg-Ependorf University Hospital uses a 3D printer to create customized, palatable medication for children undergoing cancer treatment, improving adherence and solving dosage problems; the study runs until 2026.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

How does the 3D-printing of customized medication improve pediatric cancer treatment, particularly concerning drug dosage and administration?

Researchers at Hamburg-Ependorf University Hospital (UKE) have developed a 3D-printing method to produce customized medication for children, addressing challenges in pediatric drug delivery. The study, running until 2026, focuses on dexamethasone, improving medication adherence by creating palatable, child-friendly tablets.

kathimerini.gr

🌐 85% Global Worthiness

Dec 17, 22:11

Greece Launches New Obesity Drug Amidst Booming Market

Greece launched tirzepatide, a weekly injectable obesity drug costing \"253.05 EUR\", promising \"20%\" weight loss; high demand is expected, reflecting a \"200 billion USD\" market projection by 2030 and innovation in transdermal delivery systems.

Greece Launches New Obesity Drug Amidst Booming Market

Greece launched tirzepatide, a weekly injectable obesity drug costing \"253.05 EUR\", promising \"20%\" weight loss; high demand is expected, reflecting a \"200 billion USD\" market projection by 2030 and innovation in transdermal delivery systems.

Progress

44% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What is the immediate impact of the new obesity drug, tirzepatide, on the Greek healthcare market and patient access?

A new injectable drug, tirzepatide, has launched in Greece, costing \"253.05 EUR\" per dose and promising at least \"20%\" weight loss. High demand is anticipated, with initial stock potentially depleted by January. This launch reflects a booming obesity treatment market projected to reach \"200 billion USD\" by 2030.

Showing 1 to 10 of 10 results